National Comprehensive Cancer Network



About NCCN

Occult Primary Panel - Disclosures as of 10/26/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Mark Agulnik, MD

None

None

None

None

8/21/2013

Mary Anne Bergman

None

None

None

None

9/16/2014

Marian Birkeland

None

None

None

None

10/7/2014

Daniel W. Bowles, MD

None

None

None

None

9/25/2014

Justin M. Cates, MD, PhD

None

None

None

None

5/1/2014

Mihaela Cristea, MD

None

None

None

None

7/30/2014

Efrat Dotan, MD

MedImmune Inc.;
OncoMed Pharmaceuticals;
Biocompatibles;
Immunomedics Inc.

None

None

None

9/16/2014

Keith D. Eaton, MD, PhD

None

None

None

None

7/30/2014

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Eisai Inc.;
Eli Lilly and Company;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix;
Biodesix;
Gilead;
Gilead;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

ARIAD Pharmaceuticals, Inc.

5/6/2014

Fayna Ferkle, PharmD

None

None

None

None

10/14/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

David Gierada, MD

None

None

None

None

4/22/2014

G. Weldon Gilcrease, MD

       

Pending

Kelly Godby, MD

None

None

None

None

10/7/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Charles R. Handorf, MD, PhD

None

None

None

None

9/16/2014

Renuka Iyer, MD

Genentech, Inc.

Pfizer Inc.

None

None

9/27/2014

Jeremy Kortmansky, MD

       

Pending

Renato Lenzi, MD

None

None

None

None

10/4/2013

Joan S. McClure, MS

None

None

None

None

6/20/2014

John Phay, MD

None

None

None

None

7/8/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

10/1/2014

Asif Rashid, MD

None

None

None

None

10/3/2013

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Genentech, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.

None

None

9/15/2013

Jillian L. Scavone, PhD

None

None

None

None

3/4/2014

Richard B. Schwab, MD

Galena Biopharma;
OBI Pharma

None

Samumed;
Sialix

None

9/24/2013

Lawrence N. Shulman, MD

None

None

None

None

8/26/2013

Jeffrey B. Smerage, MD, PhD

None

Amgen Inc.

None

None

9/16/2014

Marvaretta M Stevenson, MD

None

None

None

None

5/4/2014

Gauri R. Varadhachary, MD

Apocell;
Rexahn Pharmaceuticals

Celgene Corporation;
MedImmune Inc.

None

None

5/7/2014

Jonathan S. Zager, MD

None

Amgen Inc.;
Delcath Systems;
IGEA;
Provectus

None

None

4/18/2014

Weining (Ken) Zhen, MD

None

None

None

None

9/19/2014